Amy Rosenberg
Company: EpiVax, Inc
Job title: Senior Director of Immunology & Protein Therapeutics
Seminars:
What Can We Learn from Depletion of Tregs in Cancer to Enhance Treg Expansion in Autoimmune Disease, Allergy & Transplantation? 3:00 pm
Discussing drug design approaches used to elicit antitumor immunity to advance specific targeting of Tregs Utilizing next generation platforms and transcriptomic screening methods to identify Treg targets in oncology to avoid in autoimmunity Discussing learnings from clinical and nonclinical data of Treg targeting in solid tumors for a better understanding of how to selectively target…Read more
day: Day Two
Chemically Modifying IL-2 to Optimize Delivery to Tregs for Sustained Responses 3:30 pm
Overview of PEGylated IL2v to enhance activation of Tregs with high specificity and maintain stability Highlighting preclinical data to predict clinical efficacy of PEGylated IL2v Overcoming the challenges to translate from preclinical models to humansRead more
day: Day one Track 2 PM
Chair’s Opening Remarks 8:45 am
day: Day One